Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026)
Quanterix (QTRX) reported Total Non-Current Liabilities of $83.6 million for Q1 2026, up 9.46% on a YoY basis from $76.4 million in Q1 2025, and down 28.72% quarter-over-quarter from $117.4 million in Q4 2025.
Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Quanterix has reported Total Non-Current Liabilities for 10 years, with the latest figure at $83.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 9.46% year-over-year to $83.6 million; the trailing twelve-month figure through Mar 2026 stood at $83.6 million (up 9.46% YoY), and the FY2025 full-year result was $117.4 million, up 53.41% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $83.6 million, down from $117.4 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $123.7 million in Q3 2025, with the low at $69.3 million in Q1 2023.
- Historically, Total Non-Current Liabilities has averaged $80.8 million across 5 years, with a median of $76.4 million in 2025.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities retreated 9.96% — and 2025, when it surged 73.77%.
- Quanterix's Total Non-Current Liabilities stood at $74.2 million in 2022, then climbed by 4.38% to $77.4 million in 2023, then retreated by 1.21% to $76.5 million in 2024, then soared by 53.41% to $117.4 million in 2025, then retreated by 28.72% to $83.6 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $83.6 million (Q1 2026), $117.4 million (Q4 2025), and $123.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | 83.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.65 Mn |
| Dec 31, 2025 | 117.35 Mn |
| Sep 30, 2025 | 123.70 Mn |
| Jun 30, 2025 | 80.43 Mn |
| Mar 31, 2025 | 76.42 Mn |
| Dec 31, 2024 | 76.50 Mn |
| Sep 30, 2024 | 71.19 Mn |
| Jun 30, 2024 | 74.12 Mn |
| Mar 31, 2024 | 69.77 Mn |
| Dec 31, 2023 | 77.43 Mn |
| Sep 30, 2023 | 75.33 Mn |
| Jun 30, 2023 | 73.29 Mn |
| Mar 31, 2023 | 69.31 Mn |
| Dec 31, 2022 | 74.18 Mn |
| Sep 30, 2022 | 72.71 Mn |
| Jun 30, 2022 | 81.40 Mn |
| Mar 31, 2022 | 76.54 Mn |
| Dec 31, 2021 | 58.54 Mn |
| Mar 31, 2021 | 58.82 Mn |
| Dec 31, 2020 | 62.27 Mn |